Brandon Steelman, MD
About Brandon Steelman, MD
Brandon Steelman, MD, is the founder of Clear Gene and a fellow at the Royal Statistical Society. He advocates for cross-disciplinary collaboration in cancer genomics and has a strong background in molecular genetics and data science.
Work at Clear Gene
Brandon Steelman serves as the Founder of Clear Gene, a position he has held since 2012. Under his leadership, the organization focuses on advancing cancer genomics through innovative approaches. Steelman emphasizes the importance of cross-disciplinary collaboration, ensuring that all team members communicate effectively to foster innovation. His work at Clear Gene involves developing novel molecular assays that tackle complex challenges in the field.
Current Role at Royal Statistical Society
Since 2019, Brandon Steelman has been a Fellow at the Royal Statistical Society. In this role, he contributes to the advancement of statistical science and promotes the application of statistics across various disciplines. His commitment to fostering collaboration among professionals in different fields aligns with his advocacy for effective communication and innovation.
Education and Expertise
Brandon Steelman holds a Bachelor of Science in Biology and Chemistry from the University of South Carolina Upstate. He earned his Doctor of Medicine (MD) from the University of South Carolina School of Medicine. Additionally, he completed a Postdoctoral Fellowship in Molecular Genetics at Stanford University School of Medicine. His educational background provides a strong foundation for his work in cancer genomics and data science.
Research Experience
Brandon Steelman has extensive research experience, beginning with his role as an Undergraduate Research Assistant at the University of South Carolina Upstate from 1997 to 2001. He later participated in various research positions, including a Research Internship at the Oncology Research Institute of the University Hospital System and a Research Clerkship at the University of South Carolina School of Medicine. His research rotations at UC Davis further enriched his expertise in the field.
Advocacy for Innovation in Cancer Genomics
Brandon Steelman is a proponent of spanning the entire spectrum of innovation in cancer genomics, from fundamental advances to clinical translation and commercialization. He believes in the critical role of data science in developing solutions that address previously unsolvable problems in the field. His advocacy reflects a commitment to advancing the understanding and treatment of cancer through innovative methodologies.